Cargando…

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin

BACKGROUND: Dysregulation of microRNAs has been reported to be responsible for drug resistance of cancers. However, the association between aberrant expression of miR-26b and cisplatin resistance in non-small cell lung cancer (NSCLC) remains unclear. METHODS: PC9 and A549 were used to establish the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Shuzhi, Zhao, Shasha, Gao, Xinyuan, Li, Yunxia, Zhong, Chunlei, Gao, Jianlian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751336/ https://www.ncbi.nlm.nih.gov/pubmed/31686855 http://dx.doi.org/10.2147/OTT.S212649

Ejemplares similares

SNHG3 Knockdown Suppresses Proliferation, Migration and Invasion, and Promotes Apoptosis in Non-Small Cell Lung Cancer Through Regulating miR-216a/ZEB1 Axis
por: Zhao, Shasha, et al.
Publicado: (2020)

miR-125a-5p reverses epithelial-mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer
por: Li, Dongmei, et al.
Publicado: (2021)

MicroRNA-383-5p acts as a prognostic marker and inhibitor of cell proliferation in lung adenocarcinoma by cancerous inhibitor of protein phosphatase 2A
por: Zhao, Shasha, et al.
Publicado: (2017)

Annexin A11 (ANXA11) gene polymorphisms are associated with sarcoidosis in a Han Chinese population: a case–control study
por: Feng, Xianjun, et al.
Publicado: (2014)

Role of Tafazzin in Mitochondrial Function, Development and Disease
por: Chin, Michael T., et al.
Publicado: (2020)

Barth syndrome mutations that cause tafazzin complex lability
por: Claypool, Steven M., et al.
Publicado: (2011)

Drosophila tafazzin mutants have impaired exercise capacity
por: Damschroder, Deena, et al.
Publicado: (2018)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma, Yuzhu, et al.
Publicado: (2019)

Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis
por: Cadalbert, Laurence C., et al.
Publicado: (2015)

Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
por: Tomczewski, Michelle V., et al.
Publicado: (2023)

Downregulation of miR-125b promotes resistance of glioma cells to TRAIL through overexpression of Tafazzin which is a mitochondrial protein
por: Ma, Wenjia, et al.
Publicado: (2019)

Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells
por: de Taffin de Tilques, Maxence, et al.
Publicado: (2018)

Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis
por: Chen, Mei, et al.
Publicado: (2017)

Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2
por: Tian, Linli, et al.
Publicado: (2017)

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
por: Lin, Zhilai, et al.
Publicado: (2020)

Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression
por: Jagirdar, Gayatri, et al.
Publicado: (2022)

Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins
por: Claypool, Steven M., et al.
Publicado: (2006)

New C-Terminal Conserved Regions of Tafazzin, a Catalyst of Cardiolipin Remodeling
por: Shilovsky, Gregory A., et al.
Publicado: (2019)

Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism
por: Liu, Yong, et al.
Publicado: (2017)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

Corrigendum: Re-expression of tafazzin isoforms in TAZ-deficient C6 glioma cells restores cardiolipin composition but not proliferation rate and alterations in gene expression
por: Jagirdar, Gayatri, et al.
Publicado: (2022)

Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC
por: Li, Hongling, et al.
Publicado: (2022)

miR-151a induces partial EMT by regulating E-cadherin in NSCLC cells
por: Daugaard, I, et al.
Publicado: (2017)

Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown Mice
por: Powers, Corey, et al.
Publicado: (2013)

Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis
por: Shen, Yuxiu, et al.
Publicado: (2020)

Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice
por: Russo, Silvia, et al.
Publicado: (2022)

Phenotypic Characterization of Male Tafazzin-Knockout Mice at 3, 6, and 12 Months of Age
por: Tomczewski, Michelle V., et al.
Publicado: (2023)

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
por: Huang, Gang, et al.
Publicado: (2017)

Reversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene
por: Wang, Hao, et al.
Publicado: (2021)

Inhaled Cisplatin for NSCLC: Facts and Results
por: Kosmidis, Christoforos, et al.
Publicado: (2019)

Aim24 and MICOS modulate respiratory function, tafazzin-related cardiolipin modification and mitochondrial architecture
por: Harner, Max Emanuel, et al.
Publicado: (2014)

Mitochondria-Targeted Antioxidant Prevents Cardiac Dysfunction Induced by Tafazzin Gene Knockdown in Cardiac Myocytes
por: He, Quan, et al.
Publicado: (2014)

Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain
por: Hijikata, Atsushi, et al.
Publicado: (2015)

Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis [Retraction]
Publicado: (2020)

N-oleoylethanolamide treatment of lymphoblasts deficient in Tafazzin improves cell growth and mitochondrial morphology and dynamics
por: Chan, John Z., et al.
Publicado: (2022)

miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells
por: Lin, Chen, et al.
Publicado: (2018)

Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
por: Ye, Zhiqiang, et al.
Publicado: (2016)

Study on the Predictive Value of P53 Protein Expression in Brain Metastasis in NSCLC and the Mechanism of miR-424 Reversing Platinum Resistance in NSCLC
por: Deng, Yan, et al.
Publicado: (2022)

Melittin induces NSCLC apoptosis via inhibition of miR-183
por: Gao, Dongqi, et al.
Publicado: (2018)

SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling
por: Chen, Tai-yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5td187cdv8vlph8u81cocmke0